In a move poised to accelerate medical research, the Netherlands has introduced an AI-powered chatbot designed to match patients with suitable clinical trials. This innovative tool, launched in partnership with major university hospitals, leverages natural language processing to assess patient eligibility in real-time based on medical history and current health status.

The chatbot not only simplifies the application process for patients but also reduces administrative burdens for clinicians by automating initial screening steps. By providing instant feedback and personalized trial suggestions, it is expected to increase patient participation rates and improve the diversity of clinical trial cohorts. Early results suggest a significant reduction in time-to-enrollment, which could expedite the development of new therapies. For more on the use of AI in clinical trials, see this recent Nature article.